This inventor holds 2 USPTO granted patents. Top assignees: Bayer Corporation, Fujifilm Diosynth Biotechnologies U.s.a., LLC. Active years: 2002-2011.
Company Filing History:
1 out of 1,013 
1 out of 2 Years Active: 2002-2011
Title: Mark David Chavez: Innovator in Protein Purification Technologies
Introduction
Mark David Chavez is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of protein purification, holding 2 patents that showcase his innovative approaches to enhancing purification processes.
Latest Patents
Chavez's latest patents include a method for increasing dynamic binding capacity in ion exchange chromatography by the addition of polyethylene glycol. This invention relates to novel processes for protein purification in high salt solutions, such as cell culture broth, by enhancing the dynamic binding capacity of a resin. Another significant patent is the method of preparing α-1 proteinase inhibitor, which involves purifying α-1 proteinase inhibitor from aqueous solutions like human plasma. This process includes the precipitation of contaminating proteins, adjusting the conductivity of the solution, and passing it through an anion exchange resin. The methods he developed result in greater yield, purity, and pathogenic clearance of plasma fractions compared to existing methods.
Career Highlights
Throughout his career, Mark David Chavez has worked with prominent companies such as Fujifilm Diosynth Biotechnologies USA, LLC and Bayer Corporation. His experience in these organizations has allowed him to refine his skills and contribute to advancements in biotechnological processes.
Collaborations
Chavez has collaborated with notable professionals in his field, including Wytold R Lebing and Jeffrey Schrimsher. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Mark David Chavez is a distinguished inventor whose work in protein purification technologies has led to significant advancements in the field. His innovative patents and collaborations reflect his commitment to improving biotechnological processes.